## AME: AMETEK, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 1.8% below STRENGTH zone (4.0-10.0%); PEG 2.69 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($196.48)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. DA Davidson raises Ametek stock price target to $240 on growth outlook**
- Source: Investing.com | 20251209T090732 | Bullish | Relevance: 98%
-  DA Davidson has raised its price target for Ametek Inc. (NYSE:AME) to $240.00 from $235.00, maintaining a Buy rating, citing increased optimism about the company's organic growth and margin prospects through 2026. This positive outlook follows meetings with Ametekâ€™s CEO and is driven by potential strengthening in its Process and Power verticals, along with growth in medical, automation, aerospace, and defense segments. The firm views Ametek as a "best-in-class over-the-cycle outperformer" with solid financial performance and strategic leadership transitions further supporting its position.

**2. Regal Rexnord Corporation (RRX): A Bull Case Theory**
- Source: Finviz | 20251209T200940 | Somewhat-Bullish | Relevance: 64%
- This article summarizes a bullish thesis on Regal Rexnord Corporation (RRX), highlighting its transformation from a cyclical motor manufacturer into a high-margin automation and powertrain platform. The company is poised for significant growth and margin expansion as industrial markets recover, with potential 60-70% upside. Key catalysts include industrial production recovery, improved operating leverage, and validation of its emerging automation opportunities, which could drive a multiple re-rating towards historical levels.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | DA Davidson | $240 | $235 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | DA Davidson | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.91M) |
| Sells | 2 ($0.54M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (+0.6%)
- Blackrock Inc.: 8.5% (-0.9%)
- Price (T.Rowe) Assoc: 4.3% (-7.3%)
- State Street Corpora: 4.2% (+1.3%)
- JPMORGAN CHASE & CO: 3.6% (+77.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +1.9% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.69 signals overvaluation risk, limited margin of safety. Forward P/E 25.6x stretched relative to 8% growth. Quality metrics strong (margin 20%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $47.1B |
| Beta | 1.05 |
| 52W Range | $145.02 - $204.24 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.69 |
| Forward P/E | 25.6 |
| Current P/E | 27.7 |
| YoY Growth | 8.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.1% to 1.8% (+1.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.2pp (needs >4.0% for momentum thesis). MRS_5 at 1.9% confirms short-term momentum alignment. AM_20 at 4.0% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.75% (CS: 57) | Neutral |
| RSI_14 | 64.7 | Neutral |
| MACD Histogram | 0.38 | Bullish |
| vs SMA20 | 1.039x | Above |
| vs SMA50 | 1.062x | Above |
| vs SMA200 | 1.122x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $203.84
- **Stop Loss:** $196.48 (3.6% risk)
- **Target:** $211.20 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 187
- **Position Value:** $38,118.08
- **Portfolio %:** 38.12%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-03 (Est: $1.94)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.76 | $1.89 | +7.4% |
| 2025Q2 | $1.69 | $1.78 | +5.5% |
| 2025Q1 | $1.69 | $1.75 | +3.5% |
| 2024Q4 | $1.85 | $1.87 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*